{"nct_id":"NCT01316887","title":"A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","status_verified_date":"2018-04","start_date":"2011-01-01","start_date_type":null,"primary_completion_date":"2012-07-01","primary_completion_date_type":"ACTUAL","completion_date":"2012-07-21","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}